Novo Nordisk A/S
USD48.34
+0.27 (+0.56%)
CEO
Maziar Mike Doustdar
IPO Date
1981-04-30
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
DK
Open
$47.72
Prev. Close
$48.07
Day Low
$47.61
Day High
$48.48
52W Low
$35.12
52W High
$71.80
Market Cap
$214.81B
Volume
7.67M
| 27.5 |
| 31 Dec 2023 | FY | 84.6% | 36.0% | 78.5% | 26.6% | 0.25 | 0.82 | 37.4 |
| 31 Dec 2022 | FY | 83.9% | 31.4% | 66.5% | 23.0% | 0.31 | 0.89 | 38.3 |
| 31 Dec 2021 | FY | 83.2% | 33.9% | 67.5% | 24.6% | 0.38 | 0.86 | 35.4 |
| 31 Dec 2020 | FY | 83.5% | 33.2% | 66.5% | 29.1% | 0.16 | 0.94 | 23.6 |
| 31 Dec 2019 | FY | 83.5% | 31.9% | 67.6% | 31.0% | 0.08 | 1.06 | 23.6 |
| 31 Dec 2018 | FY | 84.2% | 34.5% | 74.5% | 34.9% | 0.01 | 1.09 | 19.1 |
| 31 Dec 2017 | FY | 84.2% | 34.1% | 76.5% | 37.3% | 0.03 | 1.28 | 21.7 |
| 31 Dec 2016 | FY | 84.6% | 33.9% | 83.8% | 38.9% | 0.01 | 1.26 | 17.0 |
| 13.4 |
| 30 Sept 2025 | Q3 | 76.1% | 26.7% | 11.8% | 3.9% | 0.60 | 0.78 | 19.1 |
| 30 Jun 2025 | Q2 | 83.3% | 34.5% | 15.8% | 5.5% | 0.59 | 0.78 | 18.4 |
| 31 Mar 2025 | Q1 | 83.5% | 37.2% | 21.0% | 5.9% | 0.86 | 0.74 | 18.0 |
| 31 Dec 2024 | Q4 | 84.8% | 32.9% | 19.7% | 6.1% | 0.72 | 0.74 | 24.6 |
| 30 Sept 2024 | Q3 | 84.1% | 38.3% | 22.7% | 6.9% | 0.47 | 0.94 | 32.1 |
| 30 Jun 2024 | Q2 | 84.9% | 29.5% | 17.8% | 5.4% | 0.51 | 0.94 | 55.8 |
| 31 Mar 2024 | Q1 | 84.8% | 38.9% | 25.7% | 8.5% | 0.27 | 0.70 | 38.0 |
| 31 Dec 2023 | Q4 | 84.8% | 33.3% | 20.6% | 7.0% | 0.25 | 0.82 | 35.5 |